Центральные механизмы аналгетического действия нестероидных противовоспалительных препаратов

1. <div><p>Лемина Е.Ю., Чурюканов В.В. Центральный компонент в механизме болеутоляющего действия нестероидных противовоспалительных средств. Эксп. клинич. фармакол., 1995,58, 4, 59-62</p><p>Akada S., Takeda S., Ogawa R. Salicylate action on medullary inspiratory neuron activity in a brainstem-spinal cord preparation from newborn rats. Anesth. Analg., 2003, 96, 407-411</p><p>Akaike N., Shirasaki Т., Yakushiji T. Quinolones and fenbufen interact with GABAA receptor in dissociated hippocampal cells of rat. J. Neurophysiol., 1991, 66, 497-504</p><p>Attal N., Bouhassira D. Recent pharmacologic approaches to pain. Ann. Pharm. Fr., 2000, 58, 121-134</p><p>Baron R. Neuropathic pain. The long path from mechanisms to mechanism-based treatment. Anaesthesist, 2000, 49, 373-386</p><p>Beirith A., Santos A.R., Rodrigues A.L. et al. Spinal and supraspinal antinociceptive action of dipyrone in formalin, capsaicin and glutamate tests. Study of the mechanism of action. Eur. J. Pharmacol., 1998, 345, 233-45.</p><p>Besson J.M. The complexity of physiopharmacologic aspects of pain. Drugs, 1997, 53, suppl. 2, 1-9</p><p>Burgaud J.L., Riffaud J.P., Del Soldato P. Nitric-oxide releasing molecules: a new class of drugs with several major indications.Сшт. Pharm. Des., 2002, 8, 201-213</p><p>Burian М., Tegeder I., Seegel M. et al. Peripheral and central antihyperalgesic effects of diclofenac in a model of human inflammatory pain. Clin. Pharmacol. Ther., 2003, 74, 113-120</p><p>Cadas H., Gaillet S., Beltramo M. et al. Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAM P. J. Neurosci., 1996, 16, 3934-3942</p><p>Capasso A., Sorrentino L. Arachidonic acid and its metabolites are involved in the expression of morphine dependence in guinea-pig isolated ileum. Eur. J. Pharmacol., 1997, 330, 199204</p><p>Carlsson K.H., Monzel W., Jurna 1. Depression by morphine and the non-opioid analgesic agents, metamizol (dipyrone), lysine acetylsalicylate, and paracetamol, of activity in rat thalamus neurones evoked by electrical stimulation of nociceptive afferents. Pain, 1988, 32,313-326</p><p>De Sarro A., De Sarro G. Adverse reactions to fluoroquinolones. An overview on mechanistic aspects. Curr. Med. Chem., 2001, 8, 371-384</p><p>Dickie B.G., Annels S.J., Davies J.A. Effects of cyclo-oxygenase inhibition upon glutamate release from rat cerebellum. Neuroreport, 1994, 5, 393-396.</p><p>Edwards S.R., Mather L.E., Lin Y. et al. Glutamate and kynure- nate in the rat central nervous system following treatments with tail ischaemia or diclofenac. J. Pharm. Pharmacol., 2000, 52,5966</p><p>Eisenach J.C., Curry R., Hood D.D. et al. Phase I safety assessment of intrathecal ketorolac. Pain, 2002, 99, 599-604</p><p>Eisenberg R.M. Short-term tolerance to morphine: effects of indomethacin. Life Sci., 1982, 30, 1399-1405</p><p>Farquhar-Smith W.P., Jaggar S.I., Rice A.S, Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors. Pain, 2002, 97, 11-21</p><p>Fatehi М., Tanomand A., Fatehi-Hassanabad Z. Effects of endotoxin-induced shock on withdrawal contractions in the Guinea- pig isolated ileum. Clin. Exp. Pharmacol. Physiol., 2002, 29, 608-611</p><p>Fattore L., Melis М., Diana M. et al. The cyclo-oxygenase inhibitor nimesulide induces conditioned place preference in rats. Eur.J.Pharmacol., 2000, 406, 75-77</p><p>Franklin A., Parmentier-Batteur S., Walter L. et al. Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility. J. Neurosci., 2003, 23, 7767-7775</p><p>Greffrath W., Kirschstein Т., Nawrath H. et al. Acetylsalicylic acid reduces heat responses in rat nociceptive primary sensory neurons - evidence for a new mechanism of action. Neurosci. Lett., 2002, 320,61-64</p><p>Guhring H., Gorig М., Ates M. et al. Suppressed injury-induced rise in spinal prostaglandin E2 production and reduced early thermal hyperalgesia in iNOS-deficient mice. J. Neurosci., 2000, 20, 6714-6720</p><p>Guitton M.J., Caston J., Ruel J. et al. Salicylate induces tinnitus through activation of cochlear NMDA receptors. J. Neurosci., 2003, 23, 3944-3952.</p><p>Halliwell R.F., Davey P.G., Lambert JJ. The effects of quinolones and NSAlDs upon GABA-evoked currents recorded from rat dorsal root ganglion neurones. J. Antimicrob. Chemother., 1991, 27, 209-218</p><p>Ibuki Т., Matsumura K., Yamazaki Y. et al. Cyclooxygenase-2 is induced in the endothelial cells throughout the central nervous system during carrageenan-induced hind paw inflammation; its possible role in hyperalgesia. J. Neurochem., 2003, 86, 318-328</p><p>Imanishi Т., Akahane K., Aka ike N. Evidence that a hybrid molecule of norfloxacin and biphenylacetic acid is a potent antagonist at the GABAA receptor. Neuropharmacol., 1996, 35, 12711277</p><p>Jensen S., Hansen A.C. Abuse of codeine separated from over- the-counter drugs containing acetylsalicylic acid and codeine. Int. J. Legal Med., 1993, 105, 279-281</p><p>Jerman J.C., Gray J., Brough S.J. et al. Comparison of effects of anandamide at recombinant and endogenous rat vanilloid receptors. Br. J. Anaesth., 2002, 89, 882-887</p><p>Kita H., Matsuo H., Takanaga H. et al. In vivo and in vitro toxi- codynamic analyses of new quinolone-and nonsteroidal antiinflammatory drug-induced effects on the central nervous system. Antimicrob. Agents Chemother., 1999,43, 1091-1097</p><p>Krakow M.S., Ehrenpreis E.D., Ehrenpreis S. Inhibition by indomethacin of naloxone-precipitated opiate withdrawal contraction in isolated guinea pig myenteric plexus-longitudinal muscle preparation. Life Sci., 1986, 39, 243-247</p><p>Lazaro-lbanez G.G., Torres-Lopez J.E., Granados-Soto V. Participation of the nitric oxide-cyclic GMP-ATP-sensitive K(+) channel pathway in the antinociceptive action of ketorolac. Eur. J: Pharmacol., 2001, 426, 39-44.</p><p>Lopcz-Garcia J,A„ Laird J.M. Central antinociceptive effects of meloxicam on rat spinal cord in vitro. Neuroreport, 1998, 9,647651</p><p>MacPherson R.D. New directions in pain management. Drugs Today (Bare), 2002, 38, 135-145</p><p>Mateos-Careres P.J., Garcia-Mendez A., Pdrre J. et al. Prior aspirin use in unstable angina patients with modified plasma inflammatory markers and endothelial nitric oxide synthase in neutrophils. Eur. J. Clin. Invest., 2002, 32, 895-900</p><p>McDonnell F.J., Sloan J.W., Hamann S.R. Advances in cancer pain management. Curr. Oncol. Rep., 2000, 2, 351-357</p><p>Melis М., Diana М., Gessa G.L. Cyclo-oxygenase-inhibitors increase morphine effects on mcsolimbic dopamine neurons. Eur. J. Pharmacol., 2000, 387, R1-R3</p><p>Minota S., Watanabc S. Inhibitory effects of arachidonic acid on nicotinic transmission in bullfrog sympathetic neurons. J. Neurophysiol., 1997, 78,2396-2401</p><p>Miranda H.F., Lopez J., Sierralta F. et al. NSAID antinociception measured in a chemical and a thermal assay in mice. Pain Res. Manag., 2001, 6, 190-196.</p><p>Nabeshima Т., Kameyama T. Effects of difenamizole on behavior maintained by schedule of positive reinforcement. Nippon Yakurigaku Zasshi, 1977, 73. 961-972</p><p>Niederberger E., Tegeder 1., Schafer C. et al. Opposite effects of rofecoxib on nuclear factor-kappaB and activating protein-1 activation. J. Pharmacol. Exp. Ther., 2003, 304, 1153-1160</p><p>Nielsen J.A., Sparber S.B. Indomethacin facilitates acute tolerance to and dependence upon morphine as measured by changes in fixed-ratio behavior and rectal temperature in rats. Pharmacol. Biochem. Behav., 1985, 22, 921-931</p><p>Ochi Т., Motoyama Y., Goto T. The spinal antinociceptive effect of FR140423 is mediated through kyotorphin receptors. Life Sci., 2000, 66, 2239-2245</p><p>Orti E., Coirini H., Pico J.C. Site-specific effects of the nonsteroidal anti-inflammatory drug lysine clonixinate on rat brain opioid receptors. Pharmacology, 1999. 58, 190-199</p><p>Peng B.G., Chen S., Lin X. Aspirin selectively augmented N- methyl-D-aspartate types of glutamate responses in cultured spiral ganglion neurons of mice. Neurosci. Lett., 2003, 343, 21-24</p><p>Powell K.J., Hosokawa A., Bell A. et al. Comparative effects of cyclo-oxygenase and nitric oxide synthase inhibition on the development and reversal of spinal opioid tolerance. Br. J. Pharmacol., 1999, 127, 631-644</p><p>Powell K.J., Quirion R., Jhamandas K. Inhibition of neurokinin- I- substance P receptor and prostanoid activity prevents and reverses the development of morphine tolerance in vivo and the morphine-induced increase in CG RP expression in cultured dorsal root ganglion neurons. Eur.J. Neurosci., 2003,18, 1572-1583</p><p>Ralevic V., Kendall D.A., Jerman J.C. et al. Cannabinoid activation of recombinant and endogenous vanilloid receptors. Eur. J. Pharmacol., 2001,424, 211-219</p><p>Ramer R., Brune K., Pahl A. et al. R(+)-methanandamide induces cyclooxygenase-2 expression in human neuroglioma cells via a non-cannabinoid receptor-mediated mechanism. Biochem. Biophys. Res. Commun., 2001, 286, 1144-1152</p><p>Sachs D., Cunha F.Q., Poole S. et al. Tumour necrosis factor- alpha, interleukin-1 beta and interleukin-8 induce persistent mechanical nociceptor hypersensitivity. Pain, 2002, 96, 89-97</p><p>Schwartz R.D., Yu X. Inhibition of GABA-gated chloride channel function by arachidonic acid. Brain Res., 1992, 585, 405-410</p><p>Segev S., Rehavi М., Rubinstein E. Quinolones, theophylline, and diclofenac interactions with the gamma-aminobulyric acid receptor. Antimicrob. Agents Chemother., 1988, 32, 1624-1626</p><p>Sinkkonen S.T., Mansikkamaki S., Moykkynen T. et al. Receptor subtype-dependent positive and negative modulation of GABA(A) receptor function by niflumic acid, a nonsteroidal anti-inflammatory drug. Mol. Pharmacol., 2003, 64, 753-763</p><p>Sotgiu M.L., Biella G., Formaglio F. et al. Central effect of ketorolac involving NMDA receptors activity. Brain Res., 1998, 813,223-226</p><p>Squires R.F., Ai J., Witt M.R. et al. Honokiol and magnolol increase the number of |3H)muscimol binding sites three-fold in rat forebrain membranes in vitro using a filtration assay, by allosterically increasing the affinities of low-affinity sites. Neurochem. Res., 1999, 24, 1593-1602</p><p>Squires R.F., Saederup E. Indomethacin/ibuprofen-like antiinflammatory agents selectively potentiate the gamma-aminobu- tyric acid-antagonistic effects of several norfloxacin-like quinolone antibacterial agents on |35S]t-butylbicyclophospho- rothionate binding. Mol. Pharmacol., 1993,43,795-800</p><p>Stephenson D.T., Lemere CA., Selkoe DJ. et al. Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer's disease brain. Neurobiol. Dis., 1996, 3, 51-63</p><p>Tassorelli С., Greco R., Sandrini G. et al. Central components of the arialgesic/antihyperalgesic effect of nimesulide: studies in animal models of pain and hyperalgesia. Drugs, 2003, 63, suppl. 1,9-22</p><p>Tegeder I., Niederberger E., Vatter G. et al. Effects of selective COX-1 and -2 inhibition on formalin-evoked nociceptive behaviour and prostaglandin E(2) release in the spinal cord. J. Neurochem., 2001, 79, 777-786</p><p>Tejwani G.A., Rattan A. К Antagonism of antinociception produced by intrathecal clonidine by ketorolac in the rat: the role of the opioid system. Anesth. Analg., 2000, 90, 1152-1156</p><p>Tonussi C.R., Ferreira S.H. Mechanism of diclofenac analgesia: direct blockade of inflammatory sensitization. Eur. J. Pharmacol., 1994, 251, 173-179</p><p>Trang Т., Sutak М., Quirion R. et al. The role of spinal neuropeptides and prostaglandins in opioid physical dependence. Br. J. Pharmacol., 2002, 136, 37-48</p><p>Troullos E., Hargreaves K.M., Dionne R.A. Ibuprofen elevates immunoreactive beta-endorphin levels in humans during surgical stress. Clin. Pharmacol. Then, 1997, 62, 74-81</p><p>Valeri P., Morrone L.A., Romanelli L. et al. Effect of nonsteroidal anti-inflammatory drugs on withdrawal responses in guinea pig ileum after a brief exposure to morphine. J. Pharmacol. Exp. Ther., 1993,264, 1028-1032.</p><p>Vane J. R. I nhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat. New Biol., 1971, 231, 232-235</p><p>Vaughan C.W. Enhancement of opioid inhibition of GABAergic synaptic transmission by cyclo-oxygenase inhibitors in rat periaqueductal grey neurones. Br. J. Pharmacol., 1998, 123, 14791481</p><p>Wiertelak E.P., Furness L.E., Watkins L.R. et al. Illness-induced hyperalgesia is mediated by a spinal NM DA-nitric oxide cascade. Brain Res., 1994, 664, 9-16</p><p>Wbng C.L., Wfei M.K., Roberts M.B. The effect of aspirin and paracetamol on the increased naloxone potency induced by morphine pretreatment. Eur. J. Pharmacol., 1980, 67, 241-246</p></div><br />